Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study
Authors' conclusion
These findings support the use of GRI for the assessment of the glycemic risk and the safety of specific treatment in pediatric subjects with T1D.
Study context
- Population
- Children/adolescents with T1D using CGM
- Participants
- 1,067 participants
- Exposure
- Glycemia risk index (GRI) across four treatment strategies
- Outcome
- GRI and its correlations with CGM metrics
Methodological detailsreal-life CGM data
- Real-life CGM data
Main finding
As reported in the abstract
GRI by treatment strategy
HCL
30.8
isCGM-MDIs
68.4
Observational data: associations, not effects.
Original publication
Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study. Diabetes Technol Ther. Published 26 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →